News

September 29, 2026

ExploRNA Therapeutics and Wacker Biotech are strengthening our existing R&D partnership to better serve developers in the field of nucleic acid technologies and RNA/LNP-based applications. Recognizing our complementary strengths, we have established a collaborative framework designed to facilitate seamless...

September 22, 2026

WARSAW, Poland – September 22, 2026 – ExploRNA Therapeutics, a pioneering biotechnology company specializing in novel mRNA capping technologies, and the Łukasiewicz Research Network – Industrial Chemistry Institute (Łukasiewicz – IChP) today announced a strategic partnership. The collaboration focuses...

September 14, 2026

ExploRNA Therapeutics, in collaboration with Takara Bio, has published a comprehensive technical note detailing an optimized co-transcriptional mRNA synthesis workflow that combines ExploRNA’s tetranucleotide Cap1 analog, AvantCap® Q1, with Takara Bio’s engineered PrimeCap™ T7 RNA Polymerase. Achieving efficient, clinical-grade...

July 28, 2026

ExploRNA Therapeutics today announced that AS ONE Corporation has been appointed as one of its distributors in Japan. Under the agreement, AS ONE will offer ExploRNA’s cap analog products, including ExploCap, AvantCap AG, AvantCap Q1 and AvantCap Q2, to...

July 23, 2026

ExploRNA Therapeutics was proud to take part in the 10th Central European Congress of Life Sciences (EUROBIOTECH 2026) in Kraków, Poland. As a hub for regional and global life science breakthroughs, the congress provided an ideal stage to showcase...

May 30, 2026

We are thrilled for the upcoming Biotechnology Innovation Organization Convention in San Diego. Our Board Member Tomasz Piec, and BD Director Piotr Stępniak are looking forward to meeting with partners from around the world and discussing how ExploRNA’s technology...

April 25, 2026

ExploRNA Therapeutics is pleased to announce that our Director of Business Development, Piotr Stępniak, will be attending the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Boston, taking place May 11–15, 2026. As a leading event...

March 20, 2026

Register today to join a short webinar organized by our Partner – OZ Biosciences. Use this opportunity to learn about our collaboration, mRNA platform, and listen to our Senior mRNA Scientist, Marcelina Bednarczyk, describing ExploCap and other cap analogs...

March 19, 2026

We are partnering at BioEurope Spring in Lisbon. ExploRNA Therapeutics will be represented by our Director of Business Development, Piotr Stępniak. Talk to Piotr and learn more about our capping technologies for the development of next-generation of mRNA and...

February 3, 2026

ExploRNA Therapeutics announces a strategic partnership with OZ Biosciences to broaden access to its next-generation RNA capping technology Warsaw, Poland – 03/02/2026 – ExploRNA Therapeutics, a Polish biotechnology company developing next-generation co-transcriptional RNA capping technologies (cap analogs) for high-performance...